Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.35% |
| 2 | Healthcare | 2.86% |
| 3 | Financials | 2.56% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7401
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.97B
| $718K | ﹤0.01% |
15,586
-34,853
| -69% | -$1.69M |
|
7402
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$6.79M
| $718K | ﹤0.01% |
1,946
-291
| -13% | -$109K |
|
7403
First Trust Dow Jones Select MicroCap Index Fund
FDM
$272M
| $717K | ﹤0.01% |
12,922
-3,106
| -19% | -$174K |
|
7404
CALL
Nu Skin
NUS
$236M
| $717K | ﹤0.01% |
17,000
-13,800
| -45% | -$531K |
|
7405
PUT
ProShares Short S&P500
SH
$839M
| $717K | ﹤0.01% |
11,175
+6,500
| +139% | +$417K |
|
7406
Steris
STE
$23B
| $716K | ﹤0.01% |
3,879
-98,998
| -96% | -$17.4M |
|
|
KSCD
7407
DELISTED
KFA Small Cap Quality Dividend Index ETF
KSCD
| $716K | ﹤0.01% |
28,455
+6,516
| +30% | +$173K |
|
|
AVDL
7408
DELISTED
Avadel Pharmaceuticals
AVDL
| $716K | ﹤0.01% |
99,997
+10,677
| +12% | +$74.9K |
|
7409
CALL
The Joint Corp
JYNT
$119M
| $716K | ﹤0.01% |
51,200
-13,600
| -21% | -$210K |
|
7410
iShares MSCI USA Quality Factor ETF
QUAL
$48.4B
| $715K | ﹤0.01% |
6,273
-62,790
| -91% | -$7.12M |
|
7411
BayCom
BCML
$339M
| $715K | ﹤0.01% |
37,661
-38,803
| -51% | -$730K |
|
7412
CALL
Fusion Fuel Green
HTOO
$17M
| $715K | ﹤0.01% |
4,609
+4,080
| +771% | +$641K |
|
7413
CALL
10x Genomics
TXG
$7.58B
| $714K | ﹤0.01% |
19,600
-49,200
| -72% | -$1.61M |
|
7414
Vir Biotechnology
VIR
$1.52B
| $714K | ﹤0.01% |
28,206
-93,754
| -77% | -$2.3M |
|
7415
PUT
iShares S&P 500 Growth ETF
IVW
$77.9B
| $714K | ﹤0.01% |
12,200
+2,800
| +30% | +$168K |
|
7416
PUT
iShares S&P GSCI Commodity-Indexed Trust
GSG
$932M
| $713K | ﹤0.01% |
33,600
-2,000
| -6% | -$42.9K |
|
7417
CALL
Pliant Therapeutics
PLRX
$66.9M
| $713K | ﹤0.01% |
36,900
-31,300
| -46% | -$654K |
|
7418
PUT
LGI Homes
LGIH
$1.37B
| $713K | ﹤0.01% |
7,700
-29,500
| -79% | -$2.7M |
|
|
VERV
7419
DELISTED
Verve Therapeutics
VERV
| $713K | ﹤0.01% |
36,834
-33,996
| -48% | -$901K |
|
|
REVG
7420
DELISTED
REV Group
REVG
| $712K | ﹤0.01% |
+56,437
| New | +$743K |
|
7421
PUT
IonQ
IONQ
$18.2B
| $712K | ﹤0.01% |
206,400
+51,500
| +33% | +$249K |
|
7422
CALL
Denali Therapeutics
DNLI
$3.97B
| $712K | ﹤0.01% |
25,600
+10,700
| +72% | +$318K |
|
7423
Curtiss-Wright
CW
$25.4B
| $712K | ﹤0.01% |
4,261
-15,271
| -78% | -$2.54M |
|
7424
CALL
Apogee Enterprises
APOG
$888M
| $711K | ﹤0.01% |
16,000
-10,000
| -38% | -$451K |
|
7425
CALL
Vericel Corp
VCEL
$2.28B
| $711K | ﹤0.01% |
+27,000
| New | +$643K |
|
Similar funds
Citadel Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Citadel Advisors held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in Denbury Inc. worth $107M.
- Citadel Advisors's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Citadel Advisors added most to Tesla in Q4 2022, an estimated $913M increase.
- Citadel Advisors's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Citadel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Citadel Advisors's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Citadel Advisors opened 3,614 new positions and closed 1,312 in Q4 2022.
- Citadel Advisors's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.